Cognitive and structural brain changes in ofatumumab-treated multiple sclerosis: A longitudinal study. Zanghì A, Di Filippo P S, Robusto C, Moretti M C, Avolio C, D'Amico E Neurotherapeutics. 2026 Jun 03; 23(4):e00922. PMID: 42235093. Abstract CommentRecommendBookmarkWatch
